SPY312.23+1.71 0.55%
DIA258.42+1.11 0.43%
IXIC10,207.63+53.00 0.52%

Eton Pharmaceuticals Q3 EPS $(0.28) Misses $(0.25) Estimate

Eton Pharmaceuticals (NASDAQ:ETON) reported quarterly losses of $(0.28) per share which missed the analyst consensus estimate of $(0.25) by 12 percent. This is a 56.92 percent increase over losses of $(0.65) per share

Benzinga · -

Eton Pharmaceuticals (NASDAQ:ETON) reported quarterly losses of $(0.28) per share which missed the analyst consensus estimate of $(0.25) by 12 percent. This is a 56.92 percent increase over losses of $(0.65) per share from the same period last year.